Intercept Pharmaceuticals to Participate in Piper Sandler’s 34th Annual Healthcare Conference on December 1, 2022
MORRISTOWN, N.J., Nov. 22, 2022, Intercept Pharmaceuticals (Nasdaq: ICPT) announced that Jerry Durso, President and CEO, and Andrew Saik, CFO, will participate in a fireside chat at Piper Sandler’s 34th Annual Healthcare Conference on December 1, 2022. The chat is scheduled from 2:00 p.m. to 2:25 p.m. ET, and interested investors can register through their representatives to attend. Intercept specializes in developing therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis.
- None.
- None.
MORRISTOWN, N.J., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will participate in a fireside chat at Piper Sandler’s 34th Annual Healthcare Conference, taking place in person on Thursday, December 1, 2022. The Company will also conduct meetings with investors.
Intercept's fireside chat will take place from 2:00 p.m. – 2:25 p.m. ET. To view the fireside chat, please register for the Piper Sandler 34th Annual Healthcare Conference by contacting your representative. Investors attending the conference who wish to meet with the Intercept management team, please reach out to your representative or contact Nareg Sagherian.
About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit www.interceptpharma.com or connect with the Company on Twitter and LinkedIn.
Contact
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
FAQ
What is the date and time of Intercept's fireside chat at Piper Sandler’s Healthcare Conference?
Who will represent Intercept Pharmaceuticals at the Piper Sandler conference?
How can investors view the fireside chat for Intercept Pharmaceuticals?
What is Intercept Pharmaceuticals focused on?
What diseases does Intercept Pharmaceuticals aim to treat?
